What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Category: AACR
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
The inaugural AACR Pediatric Cancer Progress Report details advances in treating children and adolescents with cancer and remaining gaps...
Steve Schneible covered the AACR Philadelphia Marathon Weekend live, including updates from his own participation in the half marathon.
Former U.S. Olympic Field Hockey player and cancer survivor Karlie Kisha is running the Philadelphia Marathon to raise money...
Past recipients of the AACR Global Scholar-in-Training Awards share how their experience with the program has been life-changing.
This year, Party with a Purpose honors melanoma researchers Lynn Schuchter and Alexander Huang, and humanitarian honoree Patricia Wellenbach.
Cancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives...
The AACR hosted a Virtual Patient Advocate Forum in July 2025 on technology’s role in cancer care.
The chairs for AACR on Campus in Malaysia share how early-career researchers can benefit from the programs in Kuala...
During his Pezcoller Foundation-AACR Award lecture, Douglas Hanahan, PhD, FAACR, highlighted ways to overcome systemic immunosuppression.